Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
161 studies found for:    Open Studies | "Mycoses"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Mycoses"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
Condition: Mycosis Fungoides
Interventions: Biological: A-dmDT390-bisFv(UCHT1);   Drug: Vorinostat
2 Recruiting PUVA Maintenance Therapy in Mycosis Fungoides
Condition: Patch/Plaque Stage Mycosis Fungoides
Intervention: Drug: 8-methoxypsoralen
3 Not yet recruiting Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method
Condition: Mycoses
Intervention:
4 Recruiting Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Intervention: Drug: Valchlor
5 Recruiting Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Campath-1H
6 Not yet recruiting TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Conditions: Mycosis Fungoides;   Sézary Syndrome
Interventions: Radiation: TSEB Therapy;   Drug: Brentuximab vedotin
7 Not yet recruiting Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
Conditions: Mycosis Fungoides;   Cutaneous T-cell Lymphoma
Interventions: Radiation: Total skin electron beam therapy (TSEBT);   Drug: mechlorethamine gel 0.016%
8 Recruiting Fungiscope - A Global Emerging Fungal Infection Registry
Condition: Invasive Fungal Disease
Intervention:
9 Not yet recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Non-Hodgkin's Lymphoma
Intervention:
10 Recruiting Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides
Conditions: Recurrent Mycosis Fungoides;   Refractory Mycosis Fungoides;   Stage I Mycosis Fungoides;   Stage II Mycosis Fungoides;   Stage III Mycosis Fungoides
Interventions: Other: Quality-of-Life Assessment;   Other: Objective Grading of Skin Findings
11 Recruiting Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
Condition: Invasive Fungal Infections
Intervention: Other: Peripheral blood sampling
12 Recruiting Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
Conditions: Mycosis Fungoides;   Sezary Syndrome;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: resminostat;   Drug: Placebo
13 Not yet recruiting Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome
Condition: Mycoses
Intervention:
14 Recruiting Effect of Inflammation on Pharmacokinetics of Posaconazole
Condition: Mycoses
Intervention: Drug: posaconazole
15 Recruiting Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype
Conditions: Cutaneous T-cell Lymphoma (CTCL);   Mycosis Fungoides
Intervention: Drug: MRG-106
16 Not yet recruiting Naloxone Hydrochloride Study for Relief of Pruritus in Patients With Mycosis Fungoides (MF) Form of CTCL
Conditions: Mycosis Fungoides;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: Naloxone Hydrochloride Lotion, 0.5%;   Drug: Placebo Lotion
17 Recruiting Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Conditions: Fungal Infection;   Hematopoietic/Lymphoid Cancer
Interventions: Drug: caspofungin acetate;   Drug: fluconazole;   Drug: voriconazole;   Other: laboratory biomarker analysis
18 Not yet recruiting Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Interventions: Drug: 3.75% Imiquimod Cream;   Drug: 0.1% Fluocinonide Cream
19 Recruiting MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
Condition: Fungal Infection
Intervention: Drug: Voriconazole
20 Recruiting Early Diagnosis of Mycosis Fungoides
Condition: Cutaneous T Cell Lymphoma
Intervention: Other: Blood sampling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.